TW200642688A - New use of PDE7 inhibitors - Google Patents

New use of PDE7 inhibitors

Info

Publication number
TW200642688A
TW200642688A TW095106687A TW95106687A TW200642688A TW 200642688 A TW200642688 A TW 200642688A TW 095106687 A TW095106687 A TW 095106687A TW 95106687 A TW95106687 A TW 95106687A TW 200642688 A TW200642688 A TW 200642688A
Authority
TW
Taiwan
Prior art keywords
new use
pde7 inhibitors
pde7
inhibitor
neuropathic pain
Prior art date
Application number
TW095106687A
Other languages
Chinese (zh)
Inventor
Peter Cox
Ross Anderson Kinloch
Graham Nigel Maw
Original Assignee
Pfizer Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Ltd filed Critical Pfizer Ltd
Publication of TW200642688A publication Critical patent/TW200642688A/en

Links

Abstract

The present invention relates to the use of a phosphodiesterase 7 (PDE7) inhibitor in the manufacture of a medicament for the treatment of neuropathic pain and to a method of treating neuropathic pain using an inhibitor of PDE7.
TW095106687A 2005-03-01 2006-02-27 New use of PDE7 inhibitors TW200642688A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0504209A GB0504209D0 (en) 2005-03-01 2005-03-01 New use of PDE7 inhibitors

Publications (1)

Publication Number Publication Date
TW200642688A true TW200642688A (en) 2006-12-16

Family

ID=34430434

Family Applications (1)

Application Number Title Priority Date Filing Date
TW095106687A TW200642688A (en) 2005-03-01 2006-02-27 New use of PDE7 inhibitors

Country Status (6)

Country Link
JP (1) JP4512052B2 (en)
CN (1) CN101146539A (en)
AR (1) AR053687A1 (en)
GB (1) GB0504209D0 (en)
TW (1) TW200642688A (en)
ZA (1) ZA200707147B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI826928B (en) * 2022-02-16 2023-12-21 翁豐富 Synthesis of tricyclic and tetracyclic genipin derivatives as anti-inflammation substance and use thereof

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102731512B (en) * 2011-04-12 2015-04-22 天津药物研究院 Preparation method of lurasidone intermediate and lurasidone
CN104211638A (en) * 2014-08-13 2014-12-17 李增 Fatty amino substituted graveoline derivative, its preparation and its application as anti-Alzheimer's disease medicine

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002076953A1 (en) * 2001-03-21 2002-10-03 Warner-Lambert Company Llc New spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors
EP1400244A1 (en) * 2002-09-17 2004-03-24 Warner-Lambert Company LLC New spirocondensed quinazolinones and their use as phosphodiesterase inhibitors

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI826928B (en) * 2022-02-16 2023-12-21 翁豐富 Synthesis of tricyclic and tetracyclic genipin derivatives as anti-inflammation substance and use thereof

Also Published As

Publication number Publication date
GB0504209D0 (en) 2005-04-06
CN101146539A (en) 2008-03-19
JP4512052B2 (en) 2010-07-28
AR053687A1 (en) 2007-05-16
ZA200707147B (en) 2008-11-26
JP2006241159A (en) 2006-09-14

Similar Documents

Publication Publication Date Title
BRPI0607402A2 (en) use of pde7 inhibitors to treat neuropathic pain
WO2004105757A3 (en) Use of rho-kinase inhibitors in the treatment of aneurysm and cardiac hypertrophy
WO2005102338A8 (en) Method of treating neuropathic pain using a crth2 receptor antagonist
IL182417A0 (en) Mitotic kinesin inhibitors and methods of use thereof
WO2009114725A3 (en) Mobilization op hematopoietic stem cells using cdc42 inhibitors
WO2007026251A3 (en) Use of dual c-kit/fgfr3 inhibitors for treating multiple myeloma
RS20050070A (en) Use of 1kb kinase inhibitors for the treatment of pain
MY138732A (en) Conjugated complement cascade inhibitors
WO2004091540A3 (en) Methods of treating pain and compositions for use therefor
WO2007120485A3 (en) Methods of treating pain with alkylxanthines and antiepileptics and compositions for use therefor
TW200716153A (en) Mitotic kinesin inhibitors and methods of use thereof
AU2003211009A8 (en) Compositions and methods for treating pain using cyclooxygenase-1 inhibitors
WO2008155390A3 (en) Use of inhibitors of sirtuins and/or ampk for the preparation of a medicament for the treatment of polyalanine diseases.
TW200642688A (en) New use of PDE7 inhibitors
ZA200710497B (en) Glepp-1 inhibitors in the treatment of autoimmune and/or inflammatory disorders
TW200503666A (en) Treatment of type 1 diabetes with pde5 inhibitors
WO2007149543A3 (en) Scar treatment using protein phosphatase inhibitors
TW200603792A (en) Monotherapy for the treatment of psoriasis with cyclooxygenase-2 selective inhibitors
WO2007097980A3 (en) Ubiquitin/proteasome inhibitors for the treatment of spinal muscular atrophy
UA96736C2 (en) Pi3k inhibitors for the treatment of endometriosis
MXPA04011018A (en) New combination of reversible proton pump inhibitors and airway therapeutics for treating airway disorders.
MX2009010757A (en) Methods of use of gamma inhibitor compounds for the attenuation of pain.
MXPA05010800A (en) Hydroxamic acids useful in the treatment of hyper-proliferative disorders.
MXPA04007007A (en) Use of inhibitors of the sodium-dependent chloride-bicarbonate-exchanger for treating thrombotic and inflammatory diseases.
PL375354A1 (en) Use of treosulfan and derivatives thereof for treating multiple sclerosis